We are live on ! Find out more
MWVC

Morgens Waterfall Vintiadis & Co Portfolio holdings

AUM $81.2M
1-Year Est. Return 86.87%
This Fund
S&P 500
This Quarter Est. Return
+7.91%
1 Year Est. Return
+86.87%
3 Year Est. Return
+484.3%
5 Year Est. Return
+875.12%
10 Year Est. Return
+12,893.79%
AUM
$156M
AUM Growth
-$23.1M
Cap. Flow
-$26.7M
Cap. Flow %
-17.14%
Top 10 Hldgs %
47.39%
Holding
62
New
19
Increased
6
Reduced
10
Closed
17

Top Buys

Rank Stock Value
1
LOW icon
Lowe's Companies
LOW
+$4.3M
2
QRVO icon
Qorvo
QRVO
+$4.17M
3
PRGO icon
Perrigo
PRGO
+$3.75M
4
GILD icon
Gilead Sciences
GILD
+$3.55M
5
AMAG
AMAG Pharmaceuticals
AMAG
+$3.34M

Top Sells

Rank Stock Value
1
TEVA icon
Teva Pharmaceuticals
TEVA
+$7.79M
2
MSFT icon
Microsoft
MSFT
+$7.57M
3
AAPL icon
Apple
AAPL
+$7.01M
4
BAC icon
Bank of America
BAC
+$5.59M
5
AMAT icon
Applied Materials
AMAT
+$5.28M

Sector Composition

Rank Sector Weight
1 Healthcare 27.84%
2 Technology 18.38%
3 Consumer Discretionary 10.04%
4 Industrials 9.96%
5 Communication Services 6.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
C icon
1
CALL
Citigroup
C
$222B
$15.5M 9.92%
300,000
– –
GILD icon
2
Gilead Sciences
GILD
$163B
$9.32M 5.98%
95,000
+35,000
+58% +$3.55M
FCH
3
DELISTED
Felcor Lodging Trust
FCH
$8.73M 5.6%
760,000
– –
META icon
4
Meta Platforms (Facebook)
META
$1.37T
$7.32M 4.69%
89,000
-10,000
-10% -$783K
PODD icon
5
Insulet
PODD
$11.5B
$7.2M 4.62%
216,000
-100,000
-32% -$3.38M
NXPI icon
6
NXP Semiconductors
NXPI
$61.8B
$5.92M 3.8%
59,000
– –
PFE icon
7
Pfizer
PFE
$142B
$5.74M 3.68%
173,910
– –
XRT icon
8
State Street SPDR S&P Retail ETF
XRT
$453M
$5.05M 3.24%
100,000
-104,000
-51% -$5.05M
QRVO icon
9
Qorvo
QRVO
$8.01B
$4.66M 2.99%
+58,500
New +$4.17M
LOW icon
10
Lowe's Companies
LOW
$118B
$4.46M 2.86%
+60,000
New +$4.3M
MA icon
11
Mastercard
MA
$510B
$4.32M 2.77%
50,000
– –
MDT icon
12
Medtronic
MDT
$110B
$4.29M 2.75%
55,000
– –
DAL icon
13
Delta Air Lines
DAL
$58.3B
$4.27M 2.74%
95,000
– –
CRDF icon
14
Cardiff Oncology
CRDF
$66.2M
$4.09M 2.62%
8,333
+3,125
+60% +$1.33M
CELG
15
DELISTED
Celgene Corp
CELG
$4.04M 2.59%
35,000
– –
FCEL icon
16
FuelCell Energy
FCEL
$1.89B
$3.94M 2.53%
730
+15
+2% +$83.2K
PRGO icon
17
Perrigo
PRGO
$1.43B
$3.89M 2.5%
+23,500
New +$3.75M
AMAG
18
DELISTED
AMAG Pharmaceuticals
AMAG
$3.83M 2.45%
+70,000
New +$3.34M
AAL icon
19
American Airlines Group
AAL
$10.2B
$3.25M 2.08%
61,500
-53,500
-47% -$2.72M
CHKP icon
20
Check Point Software Technologies
CHKP
$13.1B
$3.2M 2.05%
+39,000
New +$3.15M
ON icon
21
ON Semiconductor
ON
$32.6B
$3.15M 2.02%
+260,000
New +$2.98M
AGN
22
DELISTED
Allergan plc
AGN
$3.13M 2.01%
10,500
– –
SLAB icon
23
Silicon Laboratories
SLAB
$7.15B
$3.05M 1.95%
+60,000
New +$2.91M
ARMH
24
DELISTED
ARM HOLDINGS PLC ADS
ARMH
$2.96M 1.9%
+60,000
New +$2.98M
BYD icon
25
Boyd Gaming
BYD
$6.47B
$2.92M 1.88%
206,000
+95,000
+86% +$1.31M
1
2 3

Similar funds

RTC
Riverview Trust Company Vancouver, Washington $81.2M AUM 18.57% 1-Year Est. Return
SPW
Sonoma Private Wealth Sonoma, California $81.2M AUM 22.25% 1-Year Est. Return
MC
Medici Capital Newport Beach, California $81.2M AUM 76.04% 1-Year Est. Return
FPAM
Feynman Point Asset Management New York $81.1M AUM
BCM
Beaumont Capital Management Boston, Massachusetts $81M AUM 17.14% 1-Year Est. Return
QM
QVIDTVM Management The Woodlands, Texas $81.4M AUM 2.94% 1-Year Est. Return
FF
Formulate Financial Boca Raton, Florida $81M AUM
AGFVA
Accel Growth Fund V Associates Palo Alto, California $81.7M AUM 29.05% 1-Year Est. Return

Morgens Waterfall Vintiadis & Co's Q1 2015 Portfolio in Review

As of Q1 2015, Morgens Waterfall Vintiadis & Co held 62 positions worth $156M, down 13% from $179M the previous quarter. Its ten largest holdings account for 47% of the portfolio.

Morgens Waterfall Vintiadis & Co withdrew a net $26.7M in Q1 2015, closing 17 positions and reducing 10 holdings. Its most notable exit was Teva Pharmaceuticals, an estimated $7.79M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 28% of assets, up from 26% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Morgens Waterfall Vintiadis & Co opened a new position in Lowe's Companies worth $4.46M.

  • Morgens Waterfall Vintiadis & Co's largest Q1 2015 buy was Lowe's Companies: 60,000 shares worth $4.46M.
  • Morgens Waterfall Vintiadis & Co added most to Gilead Sciences in Q1 2015, an estimated $3.55M increase.
  • Morgens Waterfall Vintiadis & Co's biggest Q1 2015 reduction was Apple, cutting an estimated $7.01M.
  • Morgens Waterfall Vintiadis & Co fully exited Teva Pharmaceuticals in Q1 2015, selling an estimated $7.79M.
  • Morgens Waterfall Vintiadis & Co's ten largest holdings make up 47% of its $156M portfolio in Q1 2015.
  • Morgens Waterfall Vintiadis & Co opened 19 new positions and closed 17 in Q1 2015.
  • Morgens Waterfall Vintiadis & Co's portfolio value fell 13% quarter-over-quarter to $156M.

Based on Morgens Waterfall Vintiadis & Co's 13F filing for Q1 2015, filed 11 May 2015.